Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2025-01-20 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
NOTIFICATION OF BOARD MEETING
Regulatory Filings Classification · 75% confidence The document is a formal Hong Kong Exchange announcement notifying investors of a forthcoming board meeting to consider and approve unaudited interim financial results. It does not provide actual financial results (so it is not an Earnings Release or Interim Report), nor does it attach or link to a report (so it is not a Report Publication Announcement). It is not a change in management, a voting result, or any other specialized category. Therefore, it falls into the general “Regulatory Filings” fallback category (RNS).
2025-01-20 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 90% confidence The document is a corporate announcement listing the company’s board of directors and their committee memberships. It does not present financial results or ESG data, nor does it indicate that it is a meeting presentation or report publication. Instead, it is a management/board change or composition notice. This aligns with the Board/Management Information category (MANG).
2025-01-13 English
PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 92% confidence The document is a formal announcement by a listed company on the Stock Exchange of Hong Kong reporting the death of an independent non-executive director and the resulting vacancy on the Board. It discusses board composition and plans to appoint a new INED under Listing Rules. This clearly falls under announcements of board changes, which is classified as Board/Management Information (MANG).
2025-01-13 English
NOTICE OF ADJUSTMENT OF CONVERSION PRICE OF US$675 MILLION 2.50% CONVERTIBLE BONDS DUE 2029
Capital/Financing Update Classification · 91% confidence The document is a short announcement notifying investors of an adjustment to the conversion price of the company’s outstanding convertible bonds. It does not present full financial results or minutes, nor is it a notice of an AGM or vote. It relates to the company’s capital structure and financing instruments (convertible bonds). Therefore, it best fits the “Capital/Financing Update” category (CAP).
2025-01-08 English
COMPLETION ANNOUNCEMENT - (1) ISSUANCE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE (2) WARRANTS ISSUANCE UNDER SPECIFIC MANDATE
Capital/Financing Update Classification · 98% confidence The document is titled “Completion Announcement” and details the issuance of US$2,000,000,000 convertible bonds and 1,150,000,000 warrants under a specific mandate, describes proceeds raised, conversion prices, share percentages, and strategic collaboration agreements. It is not a full annual or interim report, not a dividend or AGM material, and it clearly relates to the company’s fundraising and capital structure. Therefore, it falls under Capital/Financing Update.
2025-01-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
Regulatory Filings Classification · 85% confidence The document is titled “Monthly Return for Equity Issuer…” and is a periodic compliance submission to the Hong Kong Exchange detailing movements in authorised share capital and issued shares under Chapter 19B. It is not an earnings announcement, not an annual or interim report, and does not announce a one‐off transaction or capital raise. There is no report attached or being announced, but rather the actual regulatory filing itself. This falls under the general “Regulatory Filings” category (RNS).
2025-01-07 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.